Rallybio Corp (RLYB): Total Liabilities
$4.30M
As of 2025-12-31
$3.57M
As of 2026-06-30
-27.1%
3-year compound annual growth
-6.0%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.30M | -33.3% | 2026-03-16, Balance as of period end |
| 2024-12-31 | $6.45M | -31.6% | 2026-03-16, Balance as of period end |
| 2023-12-31 | $9.44M | -15.1% | 2025-03-13, Balance as of period end |
| 2022-12-31 | $11.12M | +68.9% | 2024-03-12, Balance as of period end |
| 2021-12-31 | $6.58M | +12.4% | 2023-03-06, Balance as of period end |
| 2020-12-31 | $5.86M | n/a | 2022-03-15, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Rallybio Corp (RLYB) | 2025-12-31 | $4.30M | -33.3% |
| Onconetix, Inc. (ONCO) | 2025-12-31 | $9.16M | -50.7% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $15.74M | +48.8% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $8.64M | -24.4% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $1.99M | +10.1% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $29.63M | +5.4% |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $1.57M | +30.1% |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | $2.45M | +17.9% |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | $1.61M | +19.2% |
Compare RLYB, ONCO, RFL, STTK side by side · Screen every company in Pharmaceutical Preparations ↗